Feature

Gene Editing, Gene Therapy, and RNA Medicines: Three Different Ways to Change an Outcome

In December 2023 the FDA approved Casgevy, the first CRISPR-based therapy, for sickle cell disease. Here is how gene editing, gene therapy and RNA medicines differ, and what that approval does and doesn't prove.